ArticleFrontiers in psychiatry2024
A systematic review of chatbot-assisted interventions for substance use.
Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- User Perspectives on Conversational Agents for Preventive Alcohol Self-Help: Qualitative Exploratory Study.JMIR human factors · 2026Article
- Opportunities and risks of large language models in digital interventions for substance use disorders.Current opinion in psychiatry · 2026Review
- Is Addiction Research Addicted to Artificial Intelligence? Mapping the Intersection of Artificial Intelligence, Substance Use and Mental Health Through a Bibliometric Analysis.Drug and alcohol review · 2026Review
- Development and preliminary testing of a secure large language model-based chatbot for brief alcohol counseling in young adults.Drug and alcohol dependence · 2025Article
- Perspective on Using Artificial Intelligence in Alcohol Research and Treatment: Opportunities and Ethical Considerations.Alcohol research : current reviews · 2025Review
- Using an AI-powered Mobile Application Chatbot to Address Maternal Depression Indicators and Inquiries in the Perinatal and Postpartum Periods: A Multimethod Analysis.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study systematically reviewed research on the utilization of chatbot-related technologies for the prevention, assessment, and treatment of various substance uses, including alcohol, nicotine, and other drugs. Methods: Following PRISMA guidelines, 28 articles were selected for final analysis from an initial screening of 998 references. Data were coded for multiple components, including study characteristics, intervention types, intervention contents, sample characteristics, substance use details, measurement tools, and main findings, particularly emphasizing the effectiveness of chatbot-assisted interventions on substance use and the facilitators and barriers affecting program effectiveness. Results: Half of the studies specifically targeted smoking. Furthermore, over 85% of interventions were designed to treat substance use, with 7.14% focusing on prevention and 3.57% on assessment. Perceptions of effectiveness in quitting substance use varied, ranging from 25% to 50%, while for reduced substance use, percentages ranged from 66.67% to 83.33%. Among the studies assessing statistical effectiveness (46.43%), all experimental studies, including quasi-experiments, demonstrated significant and valid effects. Notably, 30% of studies emphasized personalization and providing relevant tips or information as key facilitators. Conclusion: This study offers valuable insights into the development and validation of chatbot-assisted interventions, thereby establishing a robust foundation for their efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.